Literature DB >> 19064870

Identification, causation, alleviation, and prevention of complications (ICAP): an approach to symptom and disability management in multiple sclerosis.

Bruce A Cohen1.   

Abstract

Comprehensive management of patients with multiple sclerosis (MS) includes treatment to modify the disease course and interventions to address the persistent symptoms and consequences of this chronic illness, which can affect patients for decades. Although much excitement and attention accompanies new therapeutic initiatives for disease management, symptomatic issues are often overshadowed despite their impact on patients' daily lives. This article describes the application of an organizational scheme of identification, causation, alleviation, and prevention of complications as a tool for identifying and managing symptomatic issues in patients with MS.

Entities:  

Mesh:

Year:  2008        PMID: 19064870     DOI: 10.1212/WNL.0b013e31818f3da5

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

1.  Nurses' perspective on approaches to limit flu-like symptoms during interferon therapy for multiple sclerosis.

Authors:  Mary L Filipi; Jill Beavin; Raquel T Brillante; Kathleen Costello; Gail C Hartley; Kay Hartley; Marie Namey; Shirley O'Leary; Gina Remington
Journal:  Int J MS Care       Date:  2014

Review 2.  Sacral neuromodulation: an effective treatment for lower urinary tract symptoms in multiple sclerosis.

Authors:  Federica Puccini; Alka Bhide; Suzy Elneil; G Alessandro Digesu
Journal:  Int Urogynecol J       Date:  2015-07-09       Impact factor: 2.894

3.  Rehabilitation challenges in multiple sclerosis.

Authors:  Jack S Burks; George Kim Bigley; Harry Haydon Hill
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

Review 4.  The treatment of lower urinary tract symptoms in patients with multiple sclerosis: a systematic review.

Authors:  A Tubaro; F Puccini; C De Nunzio; G A Digesu; S Elneil; C Gobbi; V Khullar
Journal:  Curr Urol Rep       Date:  2012-10       Impact factor: 3.092

5.  Enhancing the quality of care for patients with multiple sclerosis through performance improvement CME.

Authors:  Bruce A Cohen; Ben W Thrower; Carolyn A Berry; Stephanie A Stowell; William A Mencia; Rachel B Karcher
Journal:  Neurol Clin Pract       Date:  2013-06

6.  Patient perspectives and experience with dalfampridine treatment in multiple sclerosis-related walking impairment: the step together program.

Authors:  Heidi Crayton; Matthew Sidovar; Stanley Wulf; Amy Guo
Journal:  Patient       Date:  2015-06       Impact factor: 3.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.